Skip to content

Change in AP at other companies

Pfizer logo
PfizerPFE
-$117.25M+54.2%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$5.74M-263%
AbbVie logo
AbbVieABBV
-$1.59B-129%
Immunome logo
ImmunomeIMNM
$1.42M+137%
Arcus Biosciences logo
Arcus BiosciencesRCUS
-$3M-200%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$4.24M+98.0%

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$1.78B+674%
Enterprise value$1.68B+826%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0.0×
Current ratio17.2×+12.6×

Where this comes from

Reported directly by SELLAS Life Sciences Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SELLAS Life Sciences Group, Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SELLAS Life Sciences Group, Inc.'s change in AP?
SELLAS Life Sciences Group, Inc. (SLS) reported change in AP of $685K in Q1 2026.
How has SELLAS Life Sciences Group, Inc.'s change in AP changed year-over-year?
SELLAS Life Sciences Group, Inc.'s change in AP increased by 147.3% year-over-year, from $277K to $685K.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s change in AP?
Over 2 years (2022 to 2024), SELLAS Life Sciences Group, Inc.'s change in AP has grown at a 32.8% compound annual growth rate (CAGR), from $1.21M to -$2.14M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.